nTZDpa

Biological Activity

nTZDpa is a potent, selective non-thiazolidinedione PPARγ partial agonist (EC₅₀ = 57 nM); produces ~25% maximum efficacy. Antagonizes full agonist activity by ~60% (IC₅₀ ~ 285 nM). Displays no activity at PPARα or PPARδ receptors. Produces altered receptor conformation, and regulates adipocyte development and gene expression, in a differential manner to full PPARγ agonists. Modulates metabolism and insulin sensitivity without causing cardiac hypertrophy in mice in vivo.

Technical Data

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.

Background References

1. Distinct properties and advantages of a novel peroxisome proliferator-activated protein γ selective modulator.
   Berger et al.
   Mol.Endocrinol., 2003;17:662

Product Datasheets